Jun 19, 2026
14 MIN READ

Is Wegovy or Metformin Better for Weight Loss?

Wegovy and metformin work through completely different pathways to affect weight. Semaglutide targets appetite and metabolism, while metformin improves insulin sensitivity. Understanding these differences helps you choose the right tool for your weight loss journey.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 19, 2026
14 MIN READ

is wegovy or metformin better for weight loss? — PlexusDx GLP-1 education

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Patients often wonder whether Wegovy, the brand-name semaglutide injection, or metformin—an older diabetes medication—offers better results for weight loss. Clinical trials show semaglutide produces 15–22% body weight reduction over 68 weeks, while metformin typically delivers 2–3 kg of loss in similar timeframes. These medications operate through entirely different biological mechanisms, and the choice depends on your metabolic profile, goals, and health history.

How Semaglutide (Wegovy) Produces Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your gut produces when you eat. It slows stomach emptying, increases feelings of fullness, and signals the brain's appetite centers to reduce hunger. This triple action makes you feel satisfied on smaller portions without forcing calorie restriction through willpower alone.

The medication also improves blood sugar control and may enhance metabolic rate during weight loss phases. Clinical data from the STEP trials demonstrated that participants taking semaglutide lost an average of 15 pounds per month during the first 16 weeks, with effects sustained over two years. PlexusDx offers compounded semaglutide injection starting at $149/month from licensed 503A pharmacies, making this proven GLP-1 therapy accessible without insurance or membership requirements.

Metformin's Limited Role in Weight Management

Metformin is a first-line diabetes medication that improves insulin sensitivity and reduces hepatic glucose production. Unlike semaglutide, metformin does not directly suppress appetite or increase satiety. Instead, it addresses the underlying insulin resistance that often accompanies weight gain and metabolic dysfunction, which indirectly may support modest weight loss over extended periods.

Real-world data shows metformin produces average weight loss of 1–3 kg in non-diabetic patients, with effects plateauing after 6–12 months. For comparison, semaglutide users see sustained loss continuing through the first year of treatment. Metformin works best as a foundational metabolic medication combined with lifestyle changes, while semaglutide functions as a primary weight-loss tool for individuals seeking more substantial and faster results.

Key Biological Differences Between the Two Approaches

Semaglutide activates GLP-1 receptors throughout the brain, gut, and pancreas, triggering a cascade of satiety signals that reduce food intake by 20–30%. Metformin, conversely, works at the cellular level to improve how your body handles glucose without directly affecting hunger pathways. These distinct mechanisms mean the two drugs address different root causes: GLP-1 therapy targets appetite dysregulation, while metformin targets insulin dysfunction.

For patients with insulin resistance or prediabetes, metformin may offer metabolic benefits beyond weight loss, such as reduced cardiovascular risk and lower progression to type 2 diabetes. However, if your primary goal is weight loss and you have a normal glucose metabolism, semaglutide delivers superior outcomes. PlexusDx's Precision Peptide Genetic Test identifies your GLP1R and GIPR variants—markers that predict how strongly you'll respond to GLP-1 therapy—allowing personalization before you begin treatment.

Cost, Access, and Practical Considerations

Metformin is one of the cheapest medications available, costing $4–15 per month at most pharmacies, including generic versions covered by most insurance plans. Semaglutide's brand-name Wegovy typically costs $900–1,350 monthly through insurance, with high out-of-pocket costs if coverage is denied. PlexusDx compounded semaglutide injection starts at $149/month with no insurance required, no membership fees, and HSA/FSA eligibility—making medical-grade GLP-1 therapy financially accessible for most patients.

PlexusDx also offers compounded tirzepatide injection (dual GLP-1 and GIP receptor agonist) starting at $249/month, and oral semaglutide at $249/month for those preferring tablet dosing. Your dose may need to go up over time, but your price won't—a key difference from competitor pricing models. Available in all 50 states through licensed 503A pharmacies, PlexusDx removes insurance and geographic barriers while maintaining clinical-grade compounding standards.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take metformin and semaglutide together?

Yes. Metformin and semaglutide work through different mechanisms and are often combined in clinical practice, especially for patients with insulin resistance seeking maximum metabolic benefit. Many individuals taking semaglutide for weight loss continue metformin if they have prediabetes or type 2 diabetes. Your provider can determine whether combination therapy suits your health profile.

Why does semaglutide produce faster weight loss than metformin?

Semaglutide directly signals your brain to reduce hunger and increase fullness, shrinking appetite by 20–30% within weeks. Metformin improves insulin signaling indirectly, producing modest metabolic shifts that translate to only 1–3 kg of loss. The appetite-suppression pathway activated by GLP-1 receptors is a more powerful tool for rapid weight reduction than the insulin-sensitizing effect of metformin.

Does PlexusDx compounded semaglutide work as well as Wegovy?

PlexusDx compounded semaglutide injection is manufactured in licensed 503A pharmacies to the same pharmaceutical specifications and potency as brand-name Wegovy. The active compound is identical; the difference is source and price. Starting at $149/month versus Wegovy's $900–1,350 monthly cost, PlexusDx makes proven GLP-1 therapy affordable without compromising quality or efficacy.

Who should choose metformin over semaglutide?

Metformin is the better first choice if you have prediabetes, insulin resistance, or type 2 diabetes and want to address metabolic root causes with minimal side effects and cost. However, if your primary goal is significant weight loss (15+ pounds), semaglutide delivers superior results. Some patients benefit from both: metformin as metabolic support and semaglutide as the primary weight-loss agent.

How does PlexusDx genetic testing improve treatment choice?

The Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 pathways and 49 peptides to predict your individual response to GLP-1 therapy. This test reveals whether you're a strong or moderate responder to semaglutide, helping PlexusDx clinicians optimize your starting dose and compound selection—whether semaglutide, tirzepatide, or the dual GLP-Squared formulation—for maximum weight loss and minimal side effects.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves